Ruggeri, Matteo
 Distribuzione geografica
Continente #
EU - Europa 2.893
NA - Nord America 2.405
AS - Asia 743
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 4
SA - Sud America 4
Totale 6.062
Nazione #
US - Stati Uniti d'America 2.378
IT - Italia 1.134
DE - Germania 597
CN - Cina 339
SE - Svezia 331
UA - Ucraina 268
SG - Singapore 194
FR - Francia 119
IE - Irlanda 114
GB - Regno Unito 88
ID - Indonesia 67
FI - Finlandia 63
IN - India 50
RU - Federazione Russa 46
TR - Turchia 39
ES - Italia 26
NL - Olanda 23
CA - Canada 22
CH - Svizzera 21
BE - Belgio 20
IR - Iran 15
PL - Polonia 10
KR - Corea 9
HK - Hong Kong 8
JP - Giappone 8
AU - Australia 5
EU - Europa 5
HR - Croazia 5
RO - Romania 5
CZ - Repubblica Ceca 4
AT - Austria 3
GR - Grecia 3
MX - Messico 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
EC - Ecuador 2
EE - Estonia 2
IL - Israele 2
KW - Kuwait 2
MD - Moldavia 2
MZ - Mozambico 2
VN - Vietnam 2
AL - Albania 1
AR - Argentina 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
ME - Montenegro 1
MY - Malesia 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 6.062
Città #
Chandler 434
Jacksonville 190
Ashburn 149
Ann Arbor 147
Milan 140
Singapore 140
Plan 117
Dublin 113
San Mateo 112
Cattolica 110
Nanjing 90
Woodbridge 76
Rome 68
Wilmington 68
Bremen 67
Jakarta 67
Dearborn 59
Lawrence 57
Boston 53
Mountain View 46
Nanchang 42
Munich 40
Marseille 38
Moscow 37
Seattle 37
Beijing 29
Redwood City 27
Frattamaggiore 26
Turin 26
Houston 25
Izmir 25
Shanghai 22
Boardman 19
Brussels 18
Redmond 17
Enterprise 16
Hebei 16
Jiaxing 16
Lancaster 16
New York 16
Kunming 15
Los Angeles 15
Fairfield 14
Changsha 13
Hangzhou 13
Norwalk 13
Nürnberg 13
Augusta 12
Detroit 12
Torino 12
University Park 12
Bologna 11
Bari 10
Falls Church 10
Fremont 10
Princeton 10
Como 9
Guangzhou 9
Kish 9
Kraków 9
Napoli 9
Taranto 8
Tianjin 8
Chicago 7
Hong Kong 7
Moncalieri 7
Ottawa 7
Paris 7
Pune 7
Zurich 7
Arzano 6
Cambridge 6
Chennai 6
Florence 6
Getafe 6
Mumbai 6
Shenyang 6
Andover 5
Buccinasco 5
Gaziantep 5
Genoa 5
Modena 5
Palermo 5
Parma 5
Pescia 5
Scicli 5
Trento 5
Amsterdam 4
Castellar 4
Crema 4
Düsseldorf 4
Ghedi 4
Gorgonzola 4
Icheon-si 4
London 4
Messina 4
Reggio Calabria 4
Segrate 4
Selargius 4
Stimigliano 4
Totale 3.260
Nome #
I costi socio-sanitari dell’insufficienza renale cronica 611
L'analisi dei network organizzativinei sistemi sanitari: il caso della rete di emergenza della Regione Lazio 342
Economia sanitaria 173
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 163
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 125
Cost Effectiveness Analysis of Instanyl for the Treatment of Breakthrough Cancer Pain (BtcP) 122
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use 120
Il modello WEF per la valutazione economica delle innovazioni terapeutiche in epatologia. 119
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 116
Use of robot-specific resources and operating room times: the case of Telelap Alf-X robotic hysterectomy 113
Health Technology Assessment of the anti HCV strategies in Italy: evidences from the WEF Project 109
The harmonic study: cost-effectiveness evaluation of the use of the ultrasonic scalpel in total thyroidectomy 106
Healthcare expenditure on prevention in the spending review era 103
A cost effectiveness analysis of cataract surgery 101
Money back guarantee? A cost–benefit framework of performance-based agreements (PBAs) for the reimbursement of pharmaceuticals 97
Budget Impact Analysis of Fingolimod in Relapsing Remitting Multiple Sclerosis 96
A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study. 96
Cohort Of Hcv Patients In Italy: Sizing And Treatments In A Sample Of Italian Hepatology Centers. 93
Economic evaluation of screening programs for HCV: evidence from literature. 93
Valutazione economica di Teysuno nel trattamento del Carcinoma gastrico avanzato 89
Investigating the generalizability of Economic Evaluations conducted in Italy: a critical review 89
Extending influenza vaccination to individuals aged 50–64: A budget impact analysis 88
Harmonic study: A cost-effectiveness evaluation of ultrasonically activated shears for total thyroidectomy [Lo studio HARMONIC: Valutazione costo-efficacia dell'uso del bisturi a ultrasuoni negli interventi di tiroidectomia totale] 87
Valutazione economica dei programmi di screening contro il cancro del colon retto: evidenze indirette di lungo periodo e sostenibilita` finanziaria in un’ottica di programmazione regionale 87
Economic assessment of Eltrombopag in the treatment of thrombocytopenia 87
Between rationing and rationalization. The challenges of the Italian National Health Service during the age of the great crisis 87
Economic assessment of Zostavax vaccine for the prevention of Herpes Zoster 84
L’utilizzo di modelli decisionali per le valutazioni economiche dei farmaci in Italia: stato dell’arte e prospettive future 82
The minimum clinically important difference of the EQ-5D index. 81
Clinical and economic evaluation of tapentadol ER and oxycodone/naloxone. 81
Activity-based costing analysis of the analgesic treatments used in postoperative pain management in Italy. 81
The cost-effectiveness of alternative strategies against HBV in Italy 80
A new decision model for economic evaluation of novel therapies for HCV 80
Economic Evaluation of 5-Grass Pollen Tablets Versus Placebo in the Treatment of Allergic Rhinitis in Adults 78
Patients Diagnostic Therapeutic Pathways For Hcv Patients In Italy: Impact Of Regionalization In Treatments And Guidelines. 77
Cost effectiveness analysis of transnasal fentalyl citrate in the treatment of BTcP 75
Come comunicare e trasferire i risultati delle valutazioni di HTA applicata alle vaccinazioni ai decision makers e agli stakeholders? il progetto dell’ISPOR Rome chapter 75
THE HARMONIC STUDY: COST-EFFECTIVENESS EVALUATION OF THE USE OF THE ULTRASONIC SCALPEL IN TOTAL THYROIDECTOMY. 74
Do Probability and Certainty Equivalent techniques lead to inconsistent results? Evidence from gambles involving life years and quality of life. 74
Normative needs in healthcare: toward a new conceptualization of equity and capabilities. 71
Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory. 71
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 71
Lo studio HARMONIC: valutazione costo-efficacia dell’uso del bisturi a ultrasuoni negli interventi di tiroidectomia totale 69
Valutazione economica della tossina botulinica per la profilassi dell’emicrania cronica 68
Economic Assessment of an Anti-HCV Screening Program in Italy 67
New professional roles and patient satisfaction: evidence from a European survey along three clinical pathways 66
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 65
Economic assessment of Eltrombopag in the treatment of thrombocytopenia 65
Valutazione economica di ranibizumab vs pegaptanib o vs terapia fotodinamica con verteporfina 64
Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients: Evidence from the PITER Real-World Cohort 64
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C 62
Cost effectiveness studies in HIV treatment with Lopinavir/Ritonavir: a Review. 62
New Healthcare Professional Roles in Europe: a Survey of Patients' Experiences and Views in Nine Countries 59
Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study. 58
Evolution of the healthcare expenditure in Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis. 58
The cost effectiveness of Botox in Italian patients with chronic migraine. 56
Sevelamer Is Cost-Saving vs. Calcium Carbonate in Non-Dialysis-Dependent CKD Patients in Italy: A Patient-Level Cost-Effectiveness Analysis of the INDEPENDENT Study. 54
Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort 54
Valutazione dei costi delle infezioni nosocomiali da E.Coli in un policlinico romano di 1700 posti letto 53
Analisi economica per l’estensione della vaccinazione contro l’influenza agli individui di età 50-64: risparmi sociali e analisi di Budget Impact 53
Cost-effectiveness analysis of Daclatasvir/Sofosbuvir for the treatment of the HCV patients failed after the first line with second generation of DAAs in Italy . 48
Setting research priorities in the feld of emergency management: which piece of information are you willing to pay more? 45
Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review 44
Introduction to essay health and economics 43
Is risk attitude really specific within the health context domain? Further evidence from an Italian survey using Probability Equivalent technique and face to face interviews 42
Cost effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C. 41
Is risk outcome specific within the health domain? 36
Totale 6.143
Categoria #
all - tutte 21.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.967


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020435 0 0 0 0 52 36 106 13 68 42 45 73
2020/2021718 53 157 18 61 78 16 44 26 145 22 83 15
2021/2022677 58 68 20 27 31 26 54 108 30 43 84 128
2022/20231.319 147 186 96 223 91 170 56 113 163 17 46 11
2023/2024614 36 179 20 38 32 67 20 29 18 26 83 66
2024/2025304 24 50 105 28 97 0 0 0 0 0 0 0
Totale 6.143